2024年10月8日， 杜克大学Nicholas S Heaton携手mRNA诺奖得主Drew Weissman在 《Nature Communications》杂志上发表题为“Improved influenza vaccine responses ...
【导读】用于信使核糖核酸（mRNA）递送的脂质纳米颗粒（LNPs）已取得显著进展，但脂质纳米颗粒介导的脱氧核糖核酸（DNA）递送在临床上仍面临诸多挑战。1月13日，美国贝勒医学院研究人员在期刊《Molecular Cancer》上发表了研究论文，题为 ...
A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in ...
PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential for ...
The investment firm noted that Moderna (MRNA) and Pfizer (PFE), along with Pfizer (PFE) partner BioNTech (BNTX), were being ...
NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a ...
智通财经APP获悉，杰富瑞认为，生物制药公司Arbutus Biopharma(ABUS.US)可能受益于Moderna(MRNA.US)和辉瑞(PFE.US)/葛兰素史克(GSK.US)/CureVac(CVAV.US)正在研发的H5N1禽流感疫苗 ...
Vancouver-based Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and an expansive lipid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback